<?xml version="1.0" encoding="UTF-8"?>
<p>Comparisons of the two treatment groups, who fulfilled the predetermined thresholds, were made using Fisher's exact test, differences in the sum score of the typical domain of the ACSS were assessed using the Wilcoxon–Mann–Whitney test. The distribution of the severity of typical symptoms, QoL, dynamics, and assessment of overall efficacy by investigator and patient was compared by using the chi-square test. A p-value of less than 0.05 was considered statistically significant. All analyses were considered 
 <italic>post hoc</italic> without adjustment for multiplicity. SAS 9.4 (SAS Institute Inc., Cary, NC, USA; 2010) was used for statistical analysis and graphical presentations of results. Validation of the results was performed by an independent statistician.
</p>
